# Bristol-Myers Squibb Company (BMY) — Q4-2016 Earnings Results

**Report date:** 2017-01-26 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q4-2016

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Misses on EPS — Stock Down 5.5%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.63 | N/A | -4.26% |

### Management Commentary

**Tone:** Defensive

Management expressed concern over recent performance metrics. They reiterated their commitment to navigating market challenges.

**Key quotes:**

> Management acknowledged challenges in the current market environment.

> They emphasized a focus on long-term growth despite short-term hurdles.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report indicates a slight miss on EPS expectations, contributing to a notable stock decline of 5.5%. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. The defensive tone from management suggests they are aware of the challenges ahead and are focusing on long-term strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q4-2016_